PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.
Financial Statements
- Click here to download Perkinelmer, Inc.'s Income Statement
- Click here to download Perkinelmer, Inc.'s Balance Sheet
- Click here to download Perkinelmer, Inc.'s Statement of Cash Flows
Key Info
- Industry: Analytical Laboratory Instrument Manufacturing
- Sector: Manufacturing
- CEO Name:
Key Statistics
- Stock Price: $154.41
- Dividend Yield: 0.2%
- Market Capitalization: $17,468,288,712
- Shares Outstanding: 112,091,175
- Number of Employees: 0
- Trailing 12-Month EPS: $9.56
- Trailing 12-Month DPS: $0.28
- Payout Ratio: 2.9000000000000004%
Important Dates
- Next Earnings Date: 2021-07-28
- Next Ex-Dividend Date: 2021-04-15
Price Trends
- Current Stock Price: $154.41
- 52-week high: $162.54
- 52-week low: $96.33
- 200-day moving average: $139.58
- 50-day moving average: $145.7
Performance
- 1-Month Price Return: 7.4%
- 3-Month Price Return: 21.2%
- 6-Month Price Return: 11.6%
- 1-Year Price Return: 63.2%
- 2-Year Price Return: 62.6%
- 5-Year Price Return: 207.3%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast